(1)
A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR. Journal of Pharmaceutical Negative Results 2022, 217-225. https://doi.org/10.47750/pnr.2022.13.S09.026.